Resources

Type of publications
Regions
Diseases
4864 results found
2023 ∙ NACI
Guidance on an additional COVID-19 booster dose in the spring of 2023 for individuals at high risk of severe illness due to COVID-19
Recommendation Americas Canada COVID-19
Download:
2023 ∙ NACI
Recommendations on the use of conjugate pneumococcal vaccine – 15 valent (PNEU-C-15) and 20 valent (PNEU-C-20) in adults: Economic evidence supplementary appendix
Background paper Americas Canada Pneumococcal disease
Download:
2023 ∙ NACI
Public health level recommendations on the use of pneumococcal vaccines in adults, including the use of 15-valent and 20-valent conjugate vaccines
Recommendation Americas Canada Older adults Adults Pneumococcal disease
Download:
2023 ∙ NACI
Interim guidance on the use of pneumococcal 15-valent conjugate vaccine (PNEU-C-15) in pediatric populations
Recommendation Americas Canada Newborn Pneumococcal disease
Download:
2023 ∙ Commission Technique des Vaccinations
Vaccination strategy against Covid-19: anticipation of vaccination campaigns in 2023
Recommendation Europe France COVID-19
Download:
2023 ∙ NACI
Recommendation on Repeated Seasonal Influenza Vaccination
Recommendation Americas Canada All age groups Influenza
Download:
2023 ∙ ATAGI
ATAGI 2023 booster advice
Recommendation Western Pacific Australia booster dose COVID-19
Download:
2023 ∙ ATAGI
ATAGI recommendations on use of the Pfizer bivalent (Original/Omicron BA.4/5) COVID-19 vaccine
Recommendation Western Pacific Australia Pfizer-BioNTech vaccine COVID-19
Download:
2023
Updated HPV Technical Dossier on Quadrivalent HPV (Gardasil-4valent) 1-dose Regimen
Recommendation Africa Nigeria Human papillomavirus (HPV)
Download:
2023 ∙ Conseil Supérieur de la Santé (CSS)
Pneumococcal vaccination in children and adolescents in Belgium
Recommendation Europe Belgium Children Adolescents Pneumococcal disease
Download:
Loading...